Vaccine against Ebola: Commission grants new market authorisations

Ebola vaccine

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission adopted the decision granting marketing authorisations to the company Janssen, a Johnson & Johnson company, for a vaccine against Ebola. The authorisation was granted in one month, reducing the decision-making process timing in half, further demonstrating the Commission’s commitment in placing the protection of public health as a priority.

The new Ebola vaccine, which consists of two components, called Zabdeno and Mvabea, had been in development with the support of the Commission. This decision follows a recommendation from the European Medicines Agency (EMA), which has assessed the benefits and risks of the vaccine.

Stella Kyriakides, Commissioner in charge of Health and Food Safety, said: “This is the second Ebola vaccine that the Commission authorises in less than a year and confirms once again that the EU remains at the forefront of the global effort to save lives from this virus. We know very well from the coronavirus crisis that viruses do not respect borders – protecting the health of others protects the health of all.”

Mariya Gabriel, Commissioner in charge of Research, said: Today, we can be glad to have supported the development of the Ebola vaccine with EU funding, in partnership with the European pharmaceutical sector under the Innovative Medicines Initiative. The investment from the EU’s research programme Horizon 2020 into several Innovative Medicines Initiative Ebola projects is now bearing fruit. This demonstrates, yet again, the power of collaboration and European R&I leadership to tackle global health threats. “

As explained by EMA when it recommended the approval last February, the ability of the immune system to respond to the virus after vaccination with Zabdeno and Mvabea was studied in a total of 3,367 adults, adolescents and children who participated in five clinical studies conducted in Europe, Africa and the US.

The development of the vaccine is the result of rigorous work by several projects funded with just over €130 million through the Innovative Medicines Initiative (IMI), which is partly supported by the EU’s research and innovation programme, Horizon 2020. Following a comprehensive approach, the EBOVAC 1, 2 & 3, projects assessed the safety and tolerability of the Ebola vaccine regimen through clinical trials in Europe and Africa. The EBODAC project developed a communication strategy and tools to promote the acceptance and uptake of new Ebola vaccines. Finally, the EBOMAN project focused on accelerating the development and manufacture of the vaccine.

Background

The authorisation of a medicine under the centralised procedure is a two-stage process, involving the European Medicines Agency (EMA) and the Commission. EMA assesses the benefits and risks of medicines and makes recommendations to the Commission, which then takes a final legally binding decision on whether or not the medicine can be marketed in the EU.

This decision is issued normally within the legal deadline of 67 days of the scientific opinion of EMA (for Zabdeno and Mvabea the date was 28 May). This phase includes, among other things, the translation of the product guidelines in all EU languages and a consultation with Member States. In view of the public health interest, the Commission has accelerated this process and authorised the medicine in around a month, in other words reducing the time taken for the decision-making process in half.

The assessment report for the vaccines will be published on EMA’s website.

IMI funds large-scale collaborative research projects bringing together academic and industrial partners, as well as patients and other stakeholders.

In November 2014, IMI responded very rapidly to the West Africa outbreak of Ebola by allocating €280 million to a comprehensive call for proposals to tackle a wide range of challenges in Ebola research, including vaccines development, clinical trials, storage and transport, as well as diagnostics. The first projects under the IMI Ebola+ programme started as early as January 2015 and several focused on the development of the Janssen vaccine regimen. Since 2014, IMI has funded 12 projects on Ebola and related diseases with a total combined budget of over EUR 300 million.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Parliament boosts efforts to improve its environmental performance

Our tourism system is broken – time to customize

Chart of the day: The internet has a language diversity problem

MEPs call for concrete details and novel tools to address the economic crisis

UN envoy ‘encouraged’ by latest talks on avoiding ‘worst-case scenario’ in Syria’s Idlib

EU Council approves visa-free travel for Ukraine and cement ties with Kiev

ECB will be the catalyst of Eurozone’s reunification

UN honours fallen colleagues and friends who ‘risk all to promote peace’

The European Parliament wants to stay in one place

EU-wide survey shows Europeans support the Conference on the Future of Europe

Chart of the day: These countries have the highest share of electric vehicles

Key economic forum in Russia: New technology a ‘vector of hope’ but also ‘a source of fear’ says Guterres

Fossil fuel support is rising again in a threat to climate change efforts

Universal Health Care: can it exist only in utopic society?

“As German Chancellor I want to be able to cope with the merger of the real and digital economy”, Angela Merkel from Switzerland; the Sting reports live from World Economic Forum 2015 in Davos

An economist explains how to value the internet

Where do Americans stand on immigration? They’re not as divided as you might think

More than 90 per cent of Africa migrants would make perilous Europe journey again, despite the risks

Can alternatives to rhino horn save these gentle giants?

The world has made spectacular progress in every measure of well-being. So why does almost no one know about it?

Why skills are keeping CEOs awake at night

Eastern Partnership: Commission proposes new policy objectives for beyond 2020

Health emergency preparedness and response authority (HERA): European Commission launches public consultation

Rule of Law mechanism applies without further delay as of 1 January, MEPs stress

Draghi indirectly accuses Germany of using double standards in financial issues

Online government services could change your life. But only if you have access to the internet

A new arrangement between Eurozone’s haves and have-nots

World Economic Forum launches COVID Action Platform to fight coronavirus

Accountability in Sudan ‘crucial’ to avoid ‘further bloodshed’, says UN rights office

This is how you should be social distancing – depending on where you are and what you’re doing

Draghi: Germany has to spend if Eurozone is to exit recession

State aid: France to recover €8.5 million of illegal aid to Ryanair at Montpellier airport

These photos show the world of science in stunning detail

India should ‘unlock’ freedom curbs in disputed Kashmir, urges UN human rights chief

Questions & Answers on vaccine negotiations

Key takeaways on digital currency from The Davos Agenda

UNICEF appeals for end to ‘war on children’ in Syria and Yemen

This chart shows how the energy mix is failing in the fight against climate change

Copyright: MEPs back provisional agreement

European Commission to issue €62.9 billion worth bonds under existing programmes in 2021

From Shadows to Sunlight, Paraguay’s Road to Transparency

G20 World Exclusive Interview: “The world, especially emerging economies and developing countries, require a more sustainable and quality development”, the Spokesperson of Japan underscores live from Antalya Turkey

Five-year low inflation for Eurozone and now Mario has to finally wake up the Germans

Security Council gravely concerned by Ebola outbreak in DR Congo, demands immediate end to violence hampering response

Traditional knowledge at ‘core’ of indigenous heritage, and ‘must be protected’, says UN Forum

Negotiations on new EU collective redress rules to begin

UN sees progress in fight against tobacco, warns more action needed to help people quit deadly product

One in three fish caught never gets eaten

Reception conditions for asylum-seekers agreed between MEPs and Council

UN human rights chief fears world has grown numb to Syrian carnage

Sudan: ‘Exercise utmost restraint’ urges Guterres as thousands march in Khartoum, sparking deadly clashes

All States have ‘primary responsibility’ to protect against hate attacks

Why lay people don’t expect anything good from G20

Global Citizen-Volunteer Internships

Somalia: UN Security Council condemns terrorist attack in which dozens were killed or injured

Access to healthcare: what do we lack?

Would you want to live to 150? Top quotes on what it means to grow old

How to talk to people about mental health – and support one another

How affordable clean energy solutions can tackle energy poverty

5 surprising ways digital technology is changing childhood

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s